Efficient in vivo marking of primary CD4+ T lymphocytes in nonhuman primates using a gibbon ape leukemia virus-derived retrovital vector

Blood

Volumn 89, Issue 6, 1997, Pages 1987-1995

  Bunnell, Bruce A ^b   Metzger, Mark ^b   Byrne, Ellen ^b   Morgan, Richard A ^b   Donahue, Robert E ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; EXPRESSION VECTOR; GENE EXPRESSION; GENE TRANSFER; LEUKEMIA VIRUS; LYMPH NODE; NONHUMAN; PERIPHERAL LYMPHOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROVIRUS; RHESUS MONKEY; TISSUE DISTRIBUTION;

EID: 0030899292     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.6.1987     Document Type: Article

References (30)

1. Blaese RM, Anderson WF, Culver KW: Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase (ADA) deficiency with autologous lymphocytes transduced with a human ADA gene. Hum Gene Ther 1:327, 1990
2. Morgan RA, Anderson WF: Gene therapy. Annu Rev Biochem 62:191, 1993
3. Culver K, Cornetta K, Morgan R, Morecki S, Aebersold P, Kasid A, Lotze M, Rosenberg S, Anderson WF, Blaese RM: Lymphocytes as cellular vehicles for gene therapy in mouse and man. Proc Natl Acad Sci USA 88:3155, 1991
4. VandenDriessche T, Chuah MKL, Morgan RA: Gene therapy for acquired immune deficiency syndrome, in DeVita VT, Hellamn S, Rosenberg SA (eds): AIDS Updates. Philadelphia, PA, Lippincott, 1994, p 1
5. Ferrari G, Rossini S, Nobili N, Maggioni D, Garofalo A, Giavazzi R, Mavilio F, Bordignon C: Transfer of the ADA gene into human ADA-deficient T lymphocytes reconstitutes specific immune functions. Blood 80:1120, 1992
6. Walker R, Blaese RM, Carter CS, Chang L, Klein H, Lane HC, Leitman SF, Mullen CA: A study of the safety and survival of the adoptive transfer of genetically marked syngeneic lymphocytes in HIV-infected identical twins. Hum Gene Ther 4:659, 1993
7. Blaese RM, Culver KW, Miller AD, Carter C, Fleisher T, Clerici M, Shearer G, Chang L, Chiang Y, Tolstoshev P, Greenblatt JJ, Rosenberg SA, Klein H, Berger M, Mullen CA, Ramsey J, Muul L, Morgan RA, Anderson WF: T lymphocyte-directed gene therapy for ADA-SClD: Initial trial results after 4 years. Science 270:475, 1995
8. Bordignon C, Notrarangelo LD, Nobili N, Ferrari G, Casorati G, Panina P, Mazzolari E, Maggioni D, Rossi C, Servida P, Ugazio AG, Mavilio F: Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients. Science 270:470, 1995
9. Culver KW, Morgan RA, Osborne WRA, Lee RT, Lenschow D, Able C, Cornetta K, Anderson WF, Blaese RM: In vivo expression and survival of gene-modified T lymphocytes in rhesus monkeys. Hum Gene Ther 1:399, 1990
10. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, Shaw GM: Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117, 1995
11. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123, 1995
12. Heslop HE, Ng CYC, Li C, Smith CA, Loftin SK, Krance RA, Brenner MK, Rooney CM: Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of genemodified virus-specific T lymphocytes. Nature Med 2:551, 1996
13. Michie CA, McLean A, Alcock C, Beverley Pc: Lifepan of human lymphocyte subsets defined by CD45 isoforms. Nature 360:264, 1992
14. Sprent J, Tough DF: Lymphocyte life-span and memory. Science 265:1395, 1994
15. Tough DF, Sprent J: Life span of naive memory T cells. Stem Cells 13:242, 1995
16. Goedegebuurge PS, Douville LM, Li H, Richmond GC, Schoof DD, Scavone M, Eberlein TJ: Adoptive lmmunotherapy with tumor-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma: A pilot study. J Clin Oncol 13:1939, 1995
17. Riddell SR, Elliott M, Lewinsohn DA, Gilbert MJ, Wilson L, Manley SA, Lupton SD, Overell RW, Reynolds TC, Corey L, Greenberg PD: T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nature Med 2:216, 1996
18. Bunnell BA, Muul LM, Donahue RE, Blaese RM, Morgan RA: High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes. Proc Natl Acad Sci USA 92:7739, 1995
19. VandenDriessche T, Chuah MKL, Chiang L, Chang H-K, Ensoli B, Morgan RA: Inhibition of clinical human immunodeficiency virus (HIV) type 1 isolates in primary CD4+ T lymphocytes by retroviral vectors expressing anti-HIV genes. J Virol 69:4045, 1995
20. Donahue RE, Kirby MR, Metzger ME, Agricola BA, Sellers SE, Cullis HM: Peripheral blood CD34+ cells differ from bone marrow CD34+ cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or not mobilized with granulocyte colony-stimulating factor and/or stem cell factor. Blood 87:1644, 1996
21. Donahue RE, Kessler SW, Bodine D, McDonagh K, Dunbar C, Goodman S, Agricola B, Byrne E, Raffeld M, Moen R, Bacher J, Zsebo KM, Nienhuis AW: Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med 176:1125, 1992
22. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP. Fauci AS: HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362:355, 1993
23. Embretson J, Zupanic M, Ribas JL, Burke A, Racz P, Tenner-Racz K, Haase A: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362:359, 1993
24. Miller AD, Garcia JV, von Suhr N, Lynch CM, Wilson C, Eiden MV; Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J Virol 65:2220, 1991
25. Palmer TD, Rosman GJ, Osborne WR, Miller AD: Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. Proc Natl Acad Sci USA 88:1330, 1991
26. Apperley JF, Luskey BD, Williams DA: Retroviral gene transfer of human adenosine deaminase in murine hematopoietic cells: Effect of selectable marker sequences on long-term expression. Blood 78:310, 1991
27. Chun T-W, Finzi D, Margolick J, Chadwick K, Schwartz D, Siliciano RF: In vivo fate of HIV-1 infected T cells: Quantitative analysis of the transition to stable latency. Nature Med 1:1284, 1995
28. Mullen CA, Snitzer K, Culver KW, Morgan RA, Anderson WF, Blaese RM: Molecular analysis of T lymphocyte-directed gene therapy for adenosine deaminase deficiency: Long-term expression in vivo of genes introduced with a retroviral vector. Hum Gene Ther 7:1123, 1996
29. Kohn DB, Weinberg KI, Nolta JA, Heiss LN, Lenarsky C, Crooks GM, Hanley ME, Annett G, Brooks JS, El-Khoureiy A, Lawrence K, Wells S, Moen RC, Bastian J, Williams-Herman DE, Elder M, Wara D, Bowen T, Hershfield MS, Mullen CA, Blaese RM, Parkman R: Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nature Med 1:1017, 1995
30. Woffendin C, Ranga U, Yang Z-Y, Xu L, Nabel GJ: Nonviral and viral delivery of a human immunodeficiency virus protective gene into primay human T cells. Proc Natl Acad Sci USA 93:2889, 1996